标题 |
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial
TFOX与FOLFOX一线治疗晚期HER2阴性胃或胃食管结合部腺癌患者的比较(PRODIGE 51-FFCD-GASTFOX):一项开放标签、多中心、随机、3期试验
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 | 暂无链接,等待应助者上传 |